Stockreport

OnKure Announces New Date for Upcoming Investor Call

OnKure Therapeutics, Inc. - Class A  (OKUR) 
PDF BOULDER, Colo., Nov. 25, 2024 (GLOBE NEWSWIRE) -- OnKure Therapeutics, Inc. (NASDAQ: OKUR), a clinical-stage biopharmaceutical company focused on the development of no [Read more]